Baylor University Medical Center, Dallas, TX, USA.
Baylor Scott & White The Heart Hospital, Plano, TX, USA.
Eur J Cardiothorac Surg. 2021 Nov 2;60(5):1178-1183. doi: 10.1093/ejcts/ezab177.
The International Society of Heart and Lung Transplantation (ISHLT) criteria for primary graft dysfunction (PGD) after cardiac transplantation have been shown to stratify patient outcomes up to 1 year after transplantation, but scarce data are available regarding outcomes beyond the 1st year. We sought to characterize survival of patients with PGD following cardiac transplantation beyond the 1st year.
A retrospective review of consecutive patients undergoing isolated cardiac transplantation at a single centre between 2012 and 2015 was performed. Patients were diagnosed with none, mild, moderate or severe PGD by the ISHLT criteria. Survival was ascertained from the United Network for Organ Sharing database and chart review. Kaplan-Meier curves were plotted to compare survival. The hazard ratio for mortality associated with PGD severity was estimated using Cox-proportional hazards modelling, with a pre-specified conditional survival analysis at 90 days.
A total of 257 consecutive patients underwent cardiac transplantation during the study period, of whom 73 (28%) met ISHLT criteria for PGD: 43 (17%) mild, 12 (5%) moderate and 18 (7%) severe. Patients with moderate or severe PGD had decreased survival up to 5 years after transplantation (log-rank P < 0.001). Landmark analyses demonstrated that patients with moderate or severe PGD were at increased risk of mortality during the first 90-days after transplantation as compared to those with none or mild PGD [hazard ratio (95% confidence interval) 18.9 (7.1-50.5); P < 0.001], but this hazard did not persist beyond 90-days in survivors (P = 0.64).
A diagnosis of moderate or severe PGD is associated with increased mortality up to 5 years after cardiac transplantation. However, patients with moderate or severe PGD who survive to post-transplantation day 90 are no longer at increased risk for mortality as compared to those with none or mild PGD.
国际心肺移植学会(ISHLT)心脏移植后原发性移植物功能障碍(PGD)的标准已被证明可在移植后 1 年内对患者的预后进行分层,但关于 1 年后的结果,数据很少。我们试图描述心脏移植后 1 年以上发生 PGD 的患者的生存情况。
对 2012 年至 2015 年期间在单一中心接受单纯心脏移植的连续患者进行回顾性研究。患者根据 ISHLT 标准诊断为无、轻度、中度或重度 PGD。通过器官共享联合网络数据库和病历回顾确定生存情况。绘制 Kaplan-Meier 曲线比较生存情况。使用 Cox 比例风险模型估计与 PGD 严重程度相关的死亡率风险比,并在 90 天进行预设条件生存分析。
在研究期间共有 257 例连续患者接受心脏移植,其中 73 例(28%)符合 ISHLT 诊断 PGD 的标准:43 例(17%)轻度、12 例(5%)中度和 18 例(7%)重度。中度或重度 PGD 患者的生存率在移植后 5 年内下降(对数秩检验 P<0.001)。里程碑分析表明,与无或轻度 PGD 相比,中度或重度 PGD 患者在移植后前 90 天内死亡风险增加[风险比(95%置信区间)18.9(7.1-50.5);P<0.001],但幸存者在 90 天后死亡风险不再增加(P=0.64)。
中度或重度 PGD 的诊断与心脏移植后 5 年内的死亡率增加有关。然而,与无或轻度 PGD 相比,存活至移植后第 90 天的中度或重度 PGD 患者的死亡风险不再增加。